Found: 22
Select item for more details and to access through your institution.
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
<it>Ex vivo</it> expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.
- Published in:
- International Immunology, 2005, v. 17, n. 9, p. 1143, doi. 10.1093/intimm/dxh292
- By:
- Publication type:
- Article
Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.
- Published in:
- BMC Immunology, 2008, v. 9, p. 1, doi. 10.1186/1471-2172-9-9
- By:
- Publication type:
- Article
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.
- Published in:
- BMC Immunology, 2005, v. 6, p. 17, doi. 10.1186/1471-2172-6-17
- By:
- Publication type:
- Article
Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045684
- By:
- Publication type:
- Article
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 10, p. 1701, doi. 10.1007/s00262-009-0681-z
- By:
- Publication type:
- Article
Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Active Immunotherapy with Flt3-Ligand Mobilized Peripheral Blood Dendritic Cells Loaded With Carcinoembryonic Antigen Peptide in Patients with Metastatic Malignancies.
- Published in:
- Journal of Applied Research, 2004, v. 4, n. 4, p. 554
- By:
- Publication type:
- Article
Flt3-ligand as a Vaccine Adjuvant: Results in a Study of Flt3-ligand Plus Tetanus Toxoid Immunization.
- Published in:
- Journal of Applied Research, 2004, v. 4, n. 4, p. 536
- By:
- Publication type:
- Article
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 12, p. 2893, doi. 10.1002/ijc.24995
- By:
- Publication type:
- Article
Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibition [corrected].
- Published in:
- 2012
- By:
- Publication type:
- journal article
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 42, doi. 10.1186/1479-5876-5-42
- By:
- Publication type:
- Article
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer.
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 9, doi. 10.1186/1479-5876-3-9
- By:
- Publication type:
- Article
Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 2, p. 353, doi. 10.1038/mt.2009.195
- By:
- Publication type:
- Article
Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II
- Published in:
- Molecular Therapy, 2005, v. 12, n. 5, p. 876, doi. 10.1016/j.ymthe.2005.04.024
- By:
- Publication type:
- Article
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 19, p. 1496, doi. 10.1093/jnci/djq343
- By:
- Publication type:
- Article
CpG Oligodeoxynucleotides as TLR9 Agonists.
- Published in:
- BioDrugs, 2009, v. 23, n. 7, p. 361, doi. 10.2165/11316930-000000000-00000
- By:
- Publication type:
- Article
CpG Oligodeoxynucleotides as TLR9 Agonists.
- Published in:
- BioDrugs, 2009, v. 23, n. 6, p. 361, doi. 10.2165/11316930-000000000-00000
- By:
- Publication type:
- Article
Immunologic monitoring of cellular immune responses in cancer vaccine therapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy.
- Published in:
- 2011
- By:
- Publication type:
- Editorial